Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

IOP Control – with Gene Therapy

| 3 min read

Novel Gene Therapy shows promise for treating intraocular pressure of glaucoma

Discovery & Development Drug Discovery

The Dangers of Dengue

| Neelika Malavige | 4 min read

We need more investment for research into dengue treatments that can curb the overwhelming pressure placed on healthcare systems.

Discovery & Development Drug Discovery

Nut a Problem

| Jamie Irvine | 2 min read

Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers.

Discovery & Development Drug Discovery

Cancer Treatments for Kids

| Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Discovery & Development Drug Delivery

Sleepy Hollow

| Robin Cohen | 3 min read

“The world has long needed a better vaccine delivery system.” The time of the hollow needle is over – solid dose vaccines are the future.

Discovery & Development Drug Discovery

Cell Therapy Team Up

| Jamie Irvine | 2 min read

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Discovery & Development Drug Delivery

Clever Chemistry and Cages

| Jamie Irvine | 3 min read

Self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body.

Discovery & Development Drug Discovery

Lung Cancer Collaboration

| Jamie Irvine | 2 min read

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

Discovery & Development Drug Discovery

How Custom Antibody Libraries Empower Therapeutic Antibody Bioassays

| Sponsored by Bio-Rad Laboratories | 6 min read

There are many ways to generate antibodies, but sometimes traditional methods don’t deliver what you need.

Discovery & Development Formulation

Superbugs Versus Supercomputers

| Jamie Irvine | 2 min read

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register